Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors:
Year: 2016
Citation: - JAMA Oncology. 2(12):1590-1597, 2016 Dec 01
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X
|
|
5.
|
Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. MedStar authors:
Year: 2020
Citation: - Journal of Clinical Oncology. 38(13):1419-1428, 2020 05 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Anderson GL, Aragaki AK, Barac A, Chlebowski RT, Johnson KC, Lane DS, Luo J, Manson JE, Mossavar-Rahmani Y, Neuhouser ML, Pan K, Prentice RL, Rohan TE, Snetselaar L, Thomson CA, Wactawski-Wende J, Women's Health Initiative
|
|
6.
|
Good News, Bad News, but Not Fake News. MedStar authors:
Year: 2017
Citation: - Circulation. 135(15):1413-1416, 2017 Apr 11
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
|
|
7.
|
|
|
8.
|
Racial and ethnic disparities in treatment-related heart disease mortality among US breast cancer survivors. MedStar authors:
Year: 2023
Citation: - JNCI Cancer Spectrum. 7(2), 2023 03 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Intramural
All authors: - Barac A, Berrington de Gonzalez A, Ho KL, Lawrence WR, Ramin C, Rhee J, Veiga LHS, Vo JB
|
|
9.
|
Low-Fat Dietary Modification and Risk of Ductal Carcinoma In Situ of the Breast in the Women's Health Initiative Dietary Modification Trial. MedStar authors:
Year: 2021
Citation: - Cancer Epidemiology, Biomarkers & Prevention. 30(9):1753-1756, 2021 09.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Barac A, Chlebowski R, Crane TE, Lane DS, Manson JE, Pan K, Peila R, Rohan TE, Saquib N, Shadyab AH, Tabung FK, Wassertheil-Smoller S, Zhang Z
|
|
10.
|
|
|
11.
|
|
|
12.
|
Trastuzumab-Induced Cardiomyopathy. [Review] MedStar authors:
Year: 2019
Citation: - Cardiology Clinics. 37(4):407-418, 2019 Nov.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Barac A, Barish R, Gates E
|
|
13.
|
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. MedStar authors:
Year: 2021
Citation: - Cancer. 127(4):598-608, 2021 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Banack HR, Barac A, Beebe-Dimmer JL, Caan BJ, Chlebowski RT, Foraker R, Hastert TA, Hovsepyan G, Liu S, Luo J, Manson JE, Neuhouser ML, Okwuosa TM, Pan K, Qi L, Ruterbusch JJ, Shadyab AH, Simon MS, Thomson CA, Wactawski-Wende J, Waheed N
|
|
14.
|
Breast Cancer and Heart Failure. [Review] MedStar authors:
Year: 2019
Citation: - Heart Failure Clinics. 15(1):65-75, 2019 Jan.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Almuwaqqat Z, Barac A, Meisel JL, Parashar S
|
|
15.
|
|
|
16.
|
|
|
17.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|
|
18.
|
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Herbolsheimer, Pia M
- Lynce, Filipa
- Mete, Mihriye
- Nunes, Raquel
- Shara, Nawar M
- Swain, Sandra M
- Wray, Lynette
Year: 2016
Citation: - Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- Washington Cancer Institute
- Washington Cancer Institute
- Washington Cancer Institute A
- Washington Cancer Instituteia
Department:
- MedStar Heart Institute
- MedStar Heart Institute
Medline publication type:
All authors: - Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
|
|
19.
|
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Cunningham, A
- Gallagher, Christopher
- Hofmeyer, Mark
- Srichai, M B
- Swain, Sandra M
Year: 2019
Citation: - Breast Cancer Research & Treatment. 175(3):595-603, 2019 Jun.
Institution:
- MedStar Health
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Department: - Associate Dean for Research Development
Medline publication type:
All authors: - Asch FM, Barac A, Cunningham A, Dang C, Gallagher C, Geng X, Herbolsheimer P, Hofmeyer M, Isaacs C, Lynce F, Nunes R, Pohlmann PR, Shajahan-Haq A, Smith KL, Srichai MB, Swain SM, Tan MT, Timothee P, Warren R, Yu AF
|